The next generation biopharmaceuticals

Technical Advisory Board

Per-Åke Nygren
Professor at Royal Institute of Technology (KTH), co-founder of Affibody.

Stefan Ståhl
Professor at Royal Institute of Technology (KTH), co-founder of Affibody.

Sophia Hober
Dean of Faculty and Professor at Royal Institute of Technology (KTH), co-founder of Affibody.

Amelie Eriksson Karlström
Professor at Royal Institute of Technology (KTH).

Vladimir Tolmachev
Professor at Uppsala University.

Anna Orlova
Associate Professor at Uppsala University.

John Löfblom
Assistant Professor at Royal Institute of Technology (KTH).

Torbjörn Gräslund
Lecturer at Royal Institute of Technology (KTH).

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Upcoming reports Financial calendar

  • Year-end report (February 24, 2017)